1 / 31

Introduction to ROS in the Cardiovascular System

Introduction to ROS in the Cardiovascular System. John F. Keaney, Jr., M.D. UMass Medical School Worcester, MA. Role of ROS in CV Disease: Antiquated. NEJM, 1997. Impaired Physiologic Function. Impaired Physiologic Function. Random Oxidation. Specific Signal Pathways. Normal.

aconroy
Download Presentation

Introduction to ROS in the Cardiovascular System

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Introduction to ROS inthe Cardiovascular System John F. Keaney, Jr., M.D. UMass Medical School Worcester, MA

  2. Role of ROS in CV Disease: Antiquated NEJM, 1997

  3. Impaired Physiologic Function Impaired Physiologic Function Random Oxidation Specific Signal Pathways Normal Decreased Repair Decreased Adaptive Responses Vascular and Myocardial Disease Antioxidant Defenses Enzymatic Systems: CAT, SOD, GPX Non-enzymatic systems: Glutathione Vitamins Endogenous Sources Mitochondria Peroxisomes Lipoxygenases NADPH Oxidases Cytochrome P450 ROS/RNS Homeostasis Vascular and Myocardial Disease Adapted from Finkel and Holbrook, 2007

  4. NADPH Oxidases Neutrophil “Burst” Oxidase NADPH Oxidase (Nox) Enzyme Family Bedard and Krause, Physiol. Rev. 2007;87

  5. Contemporary ROS and CV System:Major Areas of Influence Cardiac Function Hypertrophy Angiogenesis Vascular Repair Atherosclerosis Hypertension

  6. Contemporary ROS and CV System:Major Areas of Influence Cardiac Function Hypertrophy Angiogenesis Vascular Repair Atherosclerosis Hypertension

  7. NADPH Oxidase (Nox) Enzyme Family Bedard and Krause, Physiol. Rev. 2007;87

  8. Nox2 Influences Cardiac Remodeling After Myocardial Infarction • Less pathologic heart remodeling • Reduced change to the fetal gene program • Less apoptosis Hypertension. 2008 Feb;51(2):319-25

  9. NADPH Oxidase (Nox) Enzyme Family Bedard and Krause, Physiol. Rev. 2007;87

  10. Trans Aortic Constriction Model WT TAC

  11. Cardiac Nox4 is Deleterious in Pressure Overload • Less pathologic hypertrophy • Improved function (ejection fraction) • Less apoptosis Kuroda J et al. PNAS 2010;107:15565-15570

  12. Nox4 Impacts Multiple ROS Sources Kuroda J et al. PNAS 2010;107:15565-15570

  13. Interaction of ROS Sources Cave et. al. Antioxid. Redox Signal. 8, 691–728

  14. Contemporary ROS and CV System:Major Areas of Influence Cardiac Function Hypertrophy Angiogenesis Vascular Repair Atherosclerosis Hypertension

  15. NADPH Oxidase (Nox) Enzyme Family Bedard and Krause, Physiol. Rev. 2007;87

  16. NADPH Oxidase Activity and Atherosclerosis * • ApoE(-/-) mice with or without p47phox • Animals on chow followed for 30 weeks • ROS production measured by DHE staining • Atherosclerosis determined by aortic lipid content *P<0.05 * Barry-Lane et al. J. Clin. Invest. 2001;108:1513

  17. What about hypertension?

  18. Renin-Angiotensin System

  19. NADPH Oxidase (Nox) Enzyme Family Bedard and Krause, Physiol. Rev. 2007;87

  20. Nox2 and Hypertension • Less ROS produced from blood vessels • Less rise in blood pressure • Less vascular hypertrophy Landmesser, U. et al. Hypertension 2002;40:511-515

  21. Not all ROS sources are equal!

  22. NADPH Oxidase (Nox) Enzyme Family Bedard and Krause, Physiol. Rev. 2007;87

  23. BP and Hypertrophy are Distinct Ang II Infusion Matsuno, K. et al. Circulation 2005;112:2677-2685

  24. Contemporary ROS and CV System:Major Areas of Influence Cardiac Function Hypertrophy Angiogenesis Vascular Repair Atherosclerosis Hypertension

  25. NADPH Oxidase (Nox) Enzyme Family Bedard and Krause, Physiol. Rev. 2007;87

  26. Bone Marrow Nox2 is Important for Ischemia-Induced Angiogenesis • Lack of Nox2 impairs ischemia-induced angiogenesis • This effect is most prominent in bone marrow Urao, N. et al. Circ Res 2008;103:212-220

  27. IEL IEL Nox2 Modifies Arterial Injury Wild-type, 28d Nox2-/- , 28d Chen et al., PNAS 2004;101:13014-13019

  28. How about other ROS Sources?

  29. Mitochondrial ROS are Important for Hypoxic Responses Guzy et al. , Cell Metabolism, 2005

  30. Take Home Points • ROS are ubiquitous, and serve as cellular messengers • ROS responses are generally linked to injury and repair responses • ROS sources and the regulation of these sources has, thus far, proven the most fruitful means of impacting disease • NADPH oxidases are one important source of ROS in the cardiovascular system

  31. What we do not yet know • Which source(s) of ROS are specific for certain pathologic disorders • How do the different source(s) of ROS relate to each other • What are the “normal” mechanisms for specificity of ROS species • Which ROS/RNS are most important in specific disease(s)

More Related